Perception of Effort During Exercise in Patients with Chronic Hepatitis C (CH-C) and Non-Alcoholic Fatty Liver Disease (NAFLD)

被引:0
|
作者
Weinstein, Ali A. [1 ,2 ]
Price, Jillian K. [1 ,3 ]
Winter, Patrice M. [2 ,3 ]
Oe, Bibiana [1 ]
Escheik, Carey [1 ]
Loria, Anthony [1 ]
Gerber, Lynn [1 ,2 ]
Younossi, Zobair M. [1 ,4 ]
机构
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] George Mason Univ, Coll Hlth & Human Serv, Ctr Study Chron Illness & Disabil, Fairfax, VA 22030 USA
[3] George Mason Univ, Coll Hlth & Human Serv, Dept Rehabil Sci, Fairfax, VA 22030 USA
[4] Inova Fairfax Hosp, Ctr Liver Dis, Dept Med, Falls Church, VA USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
322
引用
收藏
页码:366A / 366A
页数:1
相关论文
共 50 条
  • [1] Serum apoptotic caspase activity as marker of disease severity in chronic hepatitis C (CH-C) or non-alcoholic fatty liver disease (NAFLD)
    Papatheodoridis, G. V.
    Hadziyannis, E.
    Tsochatzis, E.
    Chrysanthos, N.
    Georgiou, A.
    Kafiri, G.
    Manolakopoulos, S.
    Manesis, E. K.
    Archimandritis, A. J.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S282 - S282
  • [2] Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
    Golabi, Pegah
    Paik, James M.
    Eberly, Katherine
    de Avila, Leyla
    Alqahtani, Saleh A.
    Younossi, Zobair M.
    ANNALS OF HEPATOLOGY, 2022, 27 (01)
  • [3] Medications Affecting the Autonomic Nervous System (ANS) Do Not Explain Abnormal Diastolic Blood Pressure in Patients With Chronic Hepatitis C (Ch-C) or Non-Alcoholic Fatty Liver Disease (NAFLD)
    Price, Jillian K.
    Escheik, Carey
    Weinstein, Ali A.
    Winter, Patrice M.
    Arsalla, Zareen
    Gerber, Lynn
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2013, 144 (05) : S969 - S969
  • [4] Impact of non-alcoholic fatty liver disease (NAFLD) on chronic hepatitis B (CHB) and C (CHC)
    Markova, A. A.
    Dragneva, S. S.
    Antonov, K.
    Jelev, D.
    Kosseva, O.
    Ivanova, R.
    Gegova, A.
    Mateva, L.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S355 - S355
  • [5] Obesity and non-alcoholic fatty liver disease in chronic hepatitis C
    Younossi, ZM
    McCullough, AJ
    Ong, JP
    Barnes, DS
    Post, A
    Tavill, A
    Bringman, D
    Martin, LM
    Assmann, J
    Gramlich, T
    Mullen, KD
    O'Shea, R
    Carey, WD
    Ferguson, R
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (08) : 705 - 709
  • [6] Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease
    Cermelli, Silvia
    Ruggieri, Anna
    Marrero, Jorge A.
    Ioannou, George N.
    Beretta, Laura
    PLOS ONE, 2011, 6 (08):
  • [7] A comparison of the fibrogenic potential of non-alcoholic fatty liver disease (NAFLD) and chronic hepatitis C (HCV) by micromorphometry
    Ratziu, V.
    Charlotte, F.
    Le Naour, G.
    Bernhardt, C.
    Poynard, T.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S360 - S360
  • [8] The impact of non-alcoholic fatty liver disease (NAFLD) on chronic hepatitis B
    Bondini, Silvia
    Gramlich, Terry
    Ramsey, Lolita
    Ong, Janus P.
    Jondle, Daniel M.
    Boparai, Navdeep
    Gujral, Harpreet
    Younossi, Zobair M.
    HEPATOLOGY, 2006, 44 (04) : 655A - 655A
  • [9] The Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B and C
    Rafiq, Nila
    Younossi, Zobair M.
    PRACTICAL GASTROENTEROLOGY, 2008, 32 (07) : 14 - 28
  • [10] Perception of Effort During Activity in Patients With Chronic Hepatitis C and Nonalcoholic Fatty Liver Disease
    Weinstein, Ali A.
    Escheik, Carey
    Oe, Bibiana
    Price, Jillian K.
    Gerber, Lynn H.
    Younossi, Zobair M.
    PM&R, 2016, 8 (01) : 28 - 34